Detalhe da pesquisa
1.
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 22(10): 1438-1447, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34499874
2.
Baseline liver steatosis has no impact on liver metastases and overall survival in rectal cancer patients.
BMC Cancer
; 21(1): 253, 2021 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33750342
3.
The clinical relevance of multiple DPYD polymorphisms on patients candidate for fluoropyrimidine based-chemotherapy. An Italian case-control study.
Br J Cancer
; 120(8): 834-839, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30858516
4.
Abdominal Fat Characteristics and Mortality in Rectal Cancer: A Retrospective Study.
Nutrients
; 15(2)2023 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36678245
5.
Impact of low skeletal muscle mass and quality on clinical outcomes in patients with head and neck cancer undergoing (chemo)radiation.
Front Nutr
; 9: 994499, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36466387
6.
Multicenter Observational Study on Metastatic Non-Small Cell Lung Cancer Harboring BRAF Mutations: Focus on Clinical Characteristics and Treatment Outcome of V600E and Non-V600E Subgroups.
Cancers (Basel)
; 14(8)2022 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35454926
7.
Therapeutic Outcomes and Clinical Features of Advanced Non-Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study.
Clin Lung Cancer
; 23(7): e478-e488, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36002369
8.
The Effect of Diffuse Liver Diseases on the Occurrence of Liver Metastases in Cancer Patients: A Systematic Review and Meta-Analysis.
Cancers (Basel)
; 13(9)2021 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34067076
9.
Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study.
Cancers (Basel)
; 12(10)2020 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33065998
10.
Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study.
Clin Lung Cancer
; 21(5): e464-e473, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32276870